Loading...
159 Asia Chronic Disorder Drugs Reports
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Merck & Co. Inc., Bayer AG, Amgen Inc, AstraZeneca, Johnson & Johnson Services, Inc.
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: AbbVie Inc., Pfizer Inc., Teva Pharmaceutical, Sun Pharmaceutical Industries Ltd, Novartis AG
Country Covered: New Zealand
Study Period: 2019 - 2030
Major Players: Astellas Pharma Inc., AstraZeneca, Sanofi, Eli Lilly and Company, Janssen Pharmaceuticals
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Takeda, AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Indonesia
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Sanofi, Novo Nordisk, AstraZeneca
Country Covered: Oman
Study Period: 2019 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Country Covered: South Korea
Study Period: 2021 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Sanofi, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., AstraZeneca
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly and Company, Pfizer Inc., AstraZeneca, Johnson And Johnson
Country Covered: China
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, Novo Nordisk
Country Covered: Thailand
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Philippines
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Malaysia
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Vietnam
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: India
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: New Zealand
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lily, Novo Nordisk, Boehringer Ingelheim, Astrazeneca
Country Covered: India
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly, Astellas, Janseen, Astrazeneca
Country Covered: Malaysia
Study Period: 2019 - 2030
Major Players: Astrazeneca, Astellas, Janssen, Eli Lilly, Sanofi
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Philips, Colgate, DMG Dental, VOCO GmbH, Dentsply Sirona
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Carl Zeiss Meditec AG, Topcon Corporation
Region Covered: Asia
Study Period: 2021 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Dermamed Solutions, AbbVie Inc (Allergan, Inc), Obagi Cosmeceuticals LLC, Merz GmbH & Co. KGaA, L'Oréal SA
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic PLC, Astellas Pharma, Inc., Macleods Pharmaceuticals Ltd, Pfizer, Inc, AbbVie Ltd.
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc.,, Novartis AG, Bausch Health Companies Inc. , Johnson & Johnson
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Takeda Pharmaceutical Company Limited , Bristol-Myers Squibb, LUPIN, Accord Healthcare, Otsuka America Pharmaceutical, Inc.
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Merck & Co. Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Azurity Pharmaceuticals, Inc.
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG , Bristol-Myers Squibb, Incyte Corporation, Takeda Pharmaceutical Company Limited, Viatris (Mylan N.V.)
Region Covered: Asia
Study Period: 2019 - 2030
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Abbvie Inc. , AstraZeneca, Takeda Pharmaceutical Company Limited, Bausch Health Companies Inc. (Salix Pharmaceuticals Inc.), Johnson & Johnson(Janssen Global Services LLC)
Filter Reports
By Countries
